e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Childhood Interstitial Lung disease: A Tertiary Single Center Experience
T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), T. Sismanlar Eyuboglu (Ankara, Turkey)
Source:
International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Session:
From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Session type:
Poster Discussion
Number:
5188
Disease area:
Interstitial lung diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Ramasli Gursoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), Z. Onay (Ankara, Turkey), T. Sismanlar Eyuboglu (Ankara, Turkey). Childhood Interstitial Lung disease: A Tertiary Single Center Experience. 5188
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Dedicated Pulmonary Rehabilitation for Patients with Interstitial Lung Disease in a District General Hospital
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Five year Cohort Analysis of Non-Tuberculosis Mycobacterium Lung Disease at a Tertiary Referral Centre
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Functional Outcomes Long Term Survival and Surgical Risk After Lung Volume Reduction Surgery: A 12-year Single Center Experience.
Source: International Congress 2017 – Thoracic surgery: preoperative assessment, outcome and complications
Year: 2017
Long Term Home Oxygen Therapy for Chronic Neonatal Lung Disease: A four year Service Evaluation at Sheffield Children's Hospital
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018
The Efficacy Of Outpatient Pulmonary Rehabilitation After Bilateral Lung Transplantation; Case Series
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital.
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis:A 5-Year Cohort Study in a Azerbaijan medical University Center
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Clinical, Radiological, Microbiological and pulmonary function Spectrum of Post Tubercular Bronchiectasis A Contemporary Study from Tertiary Care Centre
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS)
Source: Virtual Congress 2021 – Imaging
Year: 2021
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Daily Physical Activity as an Outcome Measure for Pulmonary Rehabilitation in Patients Undergoing Thoracoscopic Lung Cancer Surgery.
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017
Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Is Virtual Autonomous Physiotherapist Tele-rehabilitation Program in Chronic Obstructive Pulmonary Disease equal to Hospital-Based Pulmonary Rehabilitation?
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept